Nai-Jung Chiang

9PUBLICATIONS
60CO-AUTHORS
Predictive and prognostic markersMolecular targetsCancer diagnosisCancer therapy (excl. chemotherapy and radiation therapy)Gene and molecular therapy
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (9)

|May 21, 2026
A New CA19-9 Cutoff Value Identifies Lewis Antigen Status and Refines Prognostic Stratification in PDAC.

|Mar 05, 2026
Hypoxia-induced drug-resistance bias 3D cancer spheroid drug screens.

Tiger Haoran Shi, Yu-Tang Huang, Hyunsu Jeon

|Feb 26, 2026
Mutant Isocitrate Dehydrogenase 1 Sensitizes Intrahepatic Cholangiocarcinoma Cells to MDM2 Inhibitors.

Chien-Tsung Liu, Yung-Yeh Su, Nai-Jung Chiang

|Feb 11, 2026
Battle against time for innovative cancer treatment: an updated cost-effectiveness analysis of pemigatinib in intrahepatic cholangiocarcinoma.

I-Ting Wang, Hsiao-Lin Chen, Wei-Ming Huang

|Nov 21, 2025
ACSL6 modulates docosahexaenoic acid-induced cytotoxicity to potentiate chemotherapy response in colorectal and breast cancer.

I-Sung Chen, Chi-Che Hsieh, Chun-Chun Li

|Sep 27, 2024
DKK1 as a chemoresistant protein modulates oxaliplatin responses in colorectal cancer.

Chi-Che Hsieh, Ting-Wei Li, Chun-Chun Li

Pageof 2

Frequent Collaborators

3 joint publications

Yi-Wen Tsai

3 joint publications

Chen-Han Chueh

3 joint publications

Li-Tzong Chen

3 joint publications

Yung-Yeh Su